跳至主要内容
临床试验/NCT02052271
NCT02052271已完成不适用

Thérapeutique expérimentale du Tremblement Essentiel Par la Stimulation Transcranienne Par Courant Direct (tDCS) du Cortex Cerebelleux

Institut National de la Santé Et de la Recherche Médicale, France2 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2014年6月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
16
试验地点
2
主要终点
Change from baseline in tremor amplitude on clinical rating scale

研究概览

简要总结

The purpose of this study is to determine whether transcranial cathodal direct current stimulation (tDCS) delivered over the cerebellum can improve essential tremor.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years and ≤ 65 years
  • Important essential tremor (bilateral postural and/or action tremor since more than one year)
  • Normal physical and neurological examination, except for essential tremor
  • Insufficient efficiency of usual essential tremor's treatment
  • No treatment altering the cortical excitability
  • Agreement to use a medically acceptable method of contraception throughout the study for female of childbearing potential
  • mini-mental status score >24

排除标准

  • Age < 18 years and > 65 years
  • Current neurological or psychiatric illness other than essential tremor
  • Individual who is on medication which is known to lower seizure threshold
  • Previous history of seizure, loss of conciousness or current active epilepsy
  • Contraindication for MRI or TMS study
  • Intake of antiepileptic medications for essential tremor (barbiturates, gabapentine, topiramate, clonazepam), within the 7 days preceeding the first visit
  • alcohol intake within the 24 hours preceeding the first visit
  • Pregnancy, breast feeding women and women who are of childbearing age and not practicing adequate birth control
  • Individual who have MMS ≤ 24/30 or patients legally protected or inability to provide an informed consent
  • Simultaneous participation in another clinical trial
  • Patients who are not enrolled at social security

研究组 & 干预措施

Essential tremor

Experimental

cerebellar stimulation

干预措施: Cathodal cerebellar transcranial direct current active stimulation (Device)

Placebo arm

Placebo Comparator

placebo stimulation

干预措施: Cathodal cerebellar transcranial direct current placebo stimulation (Device)

结局指标

主要结局

Change from baseline in tremor amplitude on clinical rating scale

时间窗: 10 minutes after the end of tDCS

次要结局

  • Change from baseline in tremor amplitude on electromyographic recordings(During tDCS, 10 mn, 60 mn and 90 mn after the end of tDCS)
  • Change from baseline of amplitude of motor evoked potentials elicited by TMS(10 mn, 60 mn and 90 mn after tDCS)
  • Change from baseline in tremor amplitude on clinical rating scale(During tDCS, 60 mn and 90 mn after the end of tDCS)
  • Change from baseline in tremor amplitude on accelerometric recording(During tDCS, 10 mn, 60 mn and 90 mn after the end of tDCS)
  • Change from baseline in tremor amplitude on digitized tablet(During tDCS, 10 mn, 60 mn and 90 mn after the end of tDCS)

研究者

发起方
Institut National de la Santé Et de la Recherche Médicale, France
申办方类型
Other Gov
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验